Studies

  1. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

  2. The treatment-naive microbiome in new-onset Crohn’s disease

  3. A decrease of the butyrate-producing species *Roseburia hominis* and *Faecalibacterium prausnitzii* defines dysbiosis in patients with ulcerative colitis

  4. Bacterial protein signals are associated with Crohn’s disease

  5. Disease-specific alterations in the enteric virome in inflammatory bowel disease

  6. Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease

  7. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease

  8. Patient-Specific *Bacteroides* Genome Variants in Pouchitis

  9. A novel *Ruminococcus gnavus* clade enriched in inflammatory bowel disease patients

  10. Dynamics of the human gut microbiome in inflammatory bowel disease